You are here

Implications of Benzodiazepine Exclusion Under Medicare Part D Coverage

Alan T. Kaell, MD, and Steve A. Freedman, PhD, FAAP, NASI
PDF version: 
Although the use of benzodiazepines has been reported to be associated with hip fractures in the elderly, a 2007 study reveals that no significant reduction in hip fractures resulted when the drugs were restricted. Dr. Kaell and Dr. Freedman suggest that removing this drug class from insurance coverage might not be in the best interest of patients.